Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot ...

If approved, Tzield would be the first disease-modifying therapy to delay the progression of stage 3 T1D in adults and pediatric patients eight years of age and older recently diagnosed with stage 3 ...

It’s not always that ageing has accelerated – it’s that the volume that was disguising it has melted away, revealing the ...

When the core set of symptoms are the same, how can you tell diabetes type 1.5, or LADA, apart from it's famous cousins?

There's something oh-so-special about a skincare gift, from Rhode Skin to The Ordinary, these are the treats we're coveting.

It’s powered by the brand’s Growth Factor MiniProtein which stimulates the skins collagen, elastin and hyaluronic acid levels ...

Cell and gene therapies (CGTs) are moving rapidly from specialist trials to routine care: more than thirty products are ...

Artificial intelligence is hotter than hot in the chemical and pharmaceutical industries; and triple-digit venture capital ...